Proprietary Chinese medicine preparations for curing depression after cerebral infarction

Abstract

The invention provides a Chinese patent medicine preparation for curing the depression after cerebral infarction. The invention comprises the drugs calculated according to the proportion by weight as follows: 10 to 20 parts of rhizome of Sichuan lovage, 6 to 10 parts of bupleurum root, 6 to 15 parts of polygala root, 10 to 20 parts of Chinese angelica root, 10 to 30 parts of root of herbaceous peony, 10 to 15 parts of curcuma root, 10 to 20 parts of safflower, 15 to 25 parts of arboruitae seed and 30 to 50 parts of parched wild jujube seed. The Chinese patent medicine preparation adopts the preparation method that the Chinese drug materials are ground into fine powder of more than 100 meshes according to the formulation, and are uniformly mixed, the ozone sterilization processing is performed for 20 minutes, the materials are mixed with honey and stirred uniformly, and then is processed into pill dosage form or capsule dosage form. The preparation is a pure herbal preparation, and has the advantages that the curative effect is remarkable, the production method is simple, the cost is low, the toxic and side effects are less, the preparation is easy to be accepted by the patient, the drugs are mutually combined and has the functions of dispersing and rectifying the depressed liver-energy, stimulating circulation to end stasis, eliminating sputum, inducing resuscitation, waking up the patient from inconsciousness and allaying restlessness, the preparation can be used for curing the depression after cerebral infarction with remarkable curative effect and no obvious toxic and side effects.

Description

technical field [0001] The invention relates to a Chinese patent medicine preparation for treating depression after cerebral infarction, belonging to the technical field of traditional Chinese medicine. Background technique [0002] Stroke is a common and frequently-occurring disease among middle-aged and elderly people. Post-stroke depression is one of the common complications after stroke, among which depression after cerebral infarction is more common. According to statistics, the incidence of post-stroke depression is about 22-60%. Because of its high incidence, it seriously affects the patient's initiative and enthusiasm to overcome the disease, and has a negative impact on the rehabilitation of the patient's neurological function and the prognosis of the patient. Therefore, active and effective treatment of post-stroke depression can not only alleviate the patient's mental suffering, improve the quality of life, but also increase the patient's compliance with treatment...

AI Technical Summary

Problems solved by technology

[0005] At present, Chinese patent medicines for cerebral infarction and depression are used in the treatment of depression after cerebral infarction at the same time. Medication according to the doctor's advice can achieve obvious therapeutic effect, but due to high medical expenses, inconvenient medication and poor compliance with the drug, it seriously affects the therapeutic effect